Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571291
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISFondazione IRCCS Policlinico San Matteo di PaviaActive Not Recruiting
NCT07571291Active Not Recruiting
—
DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF I...Fondazione IRCCS Policlin...
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 2
NCT07570173Not Yet Recruiting
Phase 2
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (...Merck Sharp & Dohme LLC
NCT07571174
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisEli Lilly and CompanyNot Yet RecruitingPhase 1
NCT07571174Not Yet Recruiting
Phase 1
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclero...Eli Lilly and Company
NCT07571031
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell CarcinomaFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07571031Not Yet Recruiting
—
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of...Fondazione Policlinico Un...
NCT07569406
Use of Oxiris Filter in Septic Shock Patients Requiring Renal Replacement Therapy: A Retrospective Cohort StudyClinica Universidad de Navarra, Universidad de NavarraCompleted
NCT07569406Completed
—
Use of Oxiris Filter in Septic Shock Patients Requiring Renal Replacement Therap...Clinica Universidad de Na...
NCT07569315
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-respondersBedaya HospitalNot Yet RecruitingPhase 2
NCT07569315Not Yet Recruiting
Phase 2
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger O...Bedaya Hospital
NCT07568561
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial HospitalNot Yet Recruiting
NCT07568561Not Yet Recruiting
—
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial Hosp...
NCT07570979
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate CancerNovartis PharmaceuticalsRecruitingPhase 1
NCT07570979Recruiting
Phase 1
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent o...Novartis Pharmaceuticals
NCT07569354
Recovery Among Older Adults Following Mild TBINational Institute on Aging (NIA)Recruiting
NCT07569523
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNot Yet Recruiting
NCT07569523Not Yet Recruiting
—
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Rece...
NCT07571460
Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein ThrombosisKafrelsheikh UniversityCompletedPhase 4
NCT07571460Completed
Phase 4
Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Pat...Kafrelsheikh University
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570888
This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination.Boehringer IngelheimNot Yet RecruitingPhase 4
NCT07570888Not Yet Recruiting
Phase 4
This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycop...Boehringer Ingelheim
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570186
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsOnconic Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07570186Not Yet Recruiting
Phase 1
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy...Onconic Therapeutics Inc.
NCT07569783
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Nantong UniversityNot Yet RecruitingNot Applicable
NCT07569783Not Yet Recruiting
Not Applicable
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Na...
NCT07568990
Ureteral Access Sheaths in Endoscopic Kidney Stone SurgeryHitit UniversityNot Yet RecruitingNot Applicable
NCT07568990Not Yet Recruiting
Not Applicable
Ureteral Access Sheaths in Endoscopic Kidney Stone SurgeryHitit University
NCT07569341
Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal MetastasesLinkoeping UniversityCompleted
NCT07569341Completed
—
Validation of the Classification for Resectability and Ablatability Criteria for...Linkoeping University
NCT07570940
A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting SurgeryMayo ClinicNot Yet RecruitingPhase 4
NCT07570940Not Yet Recruiting
Phase 4
A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing A...Mayo Clinic
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed3 (15%)
Active, not recruiting1 (5%)
Not Specified7 (35%)
not_applicable4 (20%)
Phase 23 (15%)
Phase 13 (15%)
Phase 43 (15%)